Keywords: generic, drug, sales, take, off, brazil, drugs
Generic drug sales take off in Brazil
Article | 03 March 2003
Sales of generic drugs in Brazil increased 45.3% to reach $205.7 millionduring the 12 months to September 2002 compared with the like, year-earlier period, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
